These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4340176)

  • 1. [Cardiovascular effects of angiotensin II implantates on the intact unanesthesized rat. A contribution to produce a medium-term experimental hypertension].
    Grieger F; Baumann H; Wolf I
    Acta Biol Med Ger; 1972; 28(1):99-107. PubMed ID: 4340176
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on rats with long-term resistance hypertension induced by daily administration of delayed-action preparations of angiotensin].
    Matthias D; Engler E; Baumann H; Wolf I
    Acta Biol Med Ger; 1973; 30(4):505-14. PubMed ID: 4353527
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.
    Falcón BL; Stewart JM; Bourassa E; Katovich MJ; Walter G; Speth RC; Sumners C; Raizada MK
    Physiol Genomics; 2004 Nov; 19(3):255-61. PubMed ID: 15383639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat.
    Hendel MD; Collister JP
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1225-30. PubMed ID: 17184505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension.
    Simon G; Abraham G; Cserep G
    Am J Hypertens; 1995 Jun; 8(6):645-50. PubMed ID: 7662251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
    Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
    Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of exogenous angiotensin II on blood pressure in experimental nephrogenic and neurogenic-interoreceptive hypertension of rats].
    Nitschkoff S; Gnüchtel U; Jonas P; Wolnik L
    Dtsch Gesundheitsw; 1969 Dec; 24(51):2401-8. PubMed ID: 4316623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of verapamil on arterial blood pressure and heart rate in awake animals with neurogenic and renal hypertension].
    Vasques EC; Mill JG; Moysés MR; da Silva FD; da Costa MB; Caldas JG; Cabral Ade M; Vassalo DV
    Arq Bras Cardiol; 1982 Aug; 39(2):99-103. PubMed ID: 7171334
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the renal effects of angiotensin II in hypertension.
    Young DB; Lohmeier TE; Hall JE; Declue JE; Bengis RG; Coleman TG; Guyton AC
    Cor Vasa; 1980; 22(1-2):49-58. PubMed ID: 7398346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resibufogenin in experimental hypertension.
    Danchuk S; Sukhanov S; Horvat D; Uddin MN; Puschett JB
    Am J Nephrol; 2008; 28(1):8-13. PubMed ID: 17890853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood pressure dynamics in the albino rat in combination with exteroreceptive stimulation factors and administration of angiotensin II].
    Kreher C; Nitschkoff S
    Dtsch Gesundheitsw; 1972 Oct; 27(42):1978-82. PubMed ID: 4343926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increase in tumor microvascular pressure by angiotensin-induced hypertension: implication for pharmacokinetic analysis of drug delivery into tumor tissue].
    Hori K; Suzuki M; Abe I; Saito S; Sato H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):953-60. PubMed ID: 6870292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medification of the hypertensive effects of catecholamines and of Val-5-angiotensin II in the rat, by the use of several estrogens].
    Limet R; Cession G; Cession-Fossion A
    C R Seances Soc Biol Fil; 1967 Nov; 161(5):1159-61. PubMed ID: 4294564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of angiotensin II administration into the hypothalamic median eminence on arterial pressure in rats].
    Gindeva R; Pencheva T; Strashimirov D
    Eksp Med Morfol; 1987; 26(4):11-4. PubMed ID: 3446482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic efficacy of etoposide injected via carotid artery with angiotensin II-induced hypertension in experimental rat gliomas].
    Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Uozumi T
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):485-7. PubMed ID: 2003744
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal extraction of angiotensin II.
    Jackson EK; Herzer WA
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1001-6. PubMed ID: 14534364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Polfos on the bleeding time. III. Changes in various parameters of the circulatory system].
    Konopelko M; Malinowska B; Chabielska E; Buczko W
    Med Pr; 1989; 40(3):147-52. PubMed ID: 2593814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.